NEW YORK, May 2, 2022 – Proskauer, a leading international law firm, announced that it advised Havencrest Capital Management, a Dallas-based lower middle-market private equity investment firm specializing in the health care industry, on the closing of its second private equity fund, Havencrest Healthcare Partners II, L.P. (Fund II). The fund exceeded its $300 million target and closed at its hard cap of $356 million.
Fund II will exclusively focus on investing in health care companies in the U.S. Havencrest seeks to partner with top management teams to acquire founder-owned companies and drive value through operating improvements as well as organic and strategic M&A growth initiatives.
The Proskauer team was led by partners Monica Arora and Chris Robinson, special funds counsel Sean Spence and associates Mark Zwany and Victoria Hay (PIF); partner Robert Sutton (Regulatory); partner Jeremy Naylor and associate Phil Lenertz (Tax); and senior counsel Adam Scoll (ERISA).
We are 800+ lawyers serving clients from 12 offices located in the leading financial and business centers in the Americas, Europe and Asia. The world’s leading organizations, companies and corporations choose us to be their representatives in their most critical situations. But more, they consider Proskauer a strategic partner to drive their business forward. We work with asset managers, major sports leagues, Fortune 500 companies, entertainment industry legends and other industry-redefining companies.
Proskauer offers a full suite of services for the investment management industry, with a market-leading global team dedicated solely to advising hedge fund, private equity and other asset managers, investment funds, financial institutions and institutional investors across all asset classes. The cross border team of over 180 lawyers is based in the U.S., UK, Asia and Latin America and includes specialists in tax, ERISA, regulation, financial services, capital markets, M&A, employment, insurance, fund finance, litigation and risk management who understand the unique technical and commercial issues relevant to investment managers.